Surface Modification of Liposomes by a Lipopolymer Targeting Prostate Specific Membrane Antigen for Theranostic Delivery in Prostate Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Surface Modification of Liposomes by a Lipopolymer Targeting Prostate Specific Membrane Antigen for Theranostic Delivery in Prostate Cancer
Authors
Keywords
-
Journal
Materials
Volume 12, Issue 5, Pages 756
Publisher
MDPI AG
Online
2019-03-06
DOI
10.3390/ma12050756
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting of folate-conjugated liposomes with co-entrapped drugs to prostate cancer cells via prostate-specific membrane antigen (PSMA)
- (2018) Yogita Patil et al. Nanomedicine-Nanotechnology Biology and Medicine
- A novel α-enolase-targeted drug delivery system for high efficacy prostate cancer therapy
- (2018) Luyao Wang et al. Nanoscale
- PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis
- (2018) Sara Bravaccini et al. Scientific Reports
- PSMA Theranostics: Current Status and Future Directions
- (2018) Kambiz Rahbar et al. Molecular Imaging
- Tuning Pharmacokinetics to Improve Tumor Accumulation of a Prostate-Specific Membrane Antigen-Targeted Phototheranostic Agent
- (2018) Kara M. Harmatys et al. BIOCONJUGATE CHEMISTRY
- Post-insertion parameters of PEG-derivatives in phosphocholine-liposomes
- (2018) Rosario Mare et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Prostate Cancer Theranostics Targeting Gastrin-Releasing Peptide Receptors
- (2017) Lucia Baratto et al. MOLECULAR IMAGING AND BIOLOGY
- Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn2+ chelator TPEN inducing oxidative stress in prostate cancer cells
- (2016) Christopher H Stuart et al. Nanomedicine
- Automated synthesis of [18F]DCFPyL via direct radiofluorination and validation in preclinical prostate cancer models
- (2016) Vincent Bouvet et al. EJNMMI Research
- Correlating lipid bilayer fluidity with sensitivity and resolution of polytopic membrane protein spectra by solid-state NMR spectroscopy
- (2015) James R. Banigan et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Liposomes Modified with Superhydrophilic Polymer Linked to a Nonphospholipid Anchor Exhibit Reduced Complement Activation and Enhanced Circulation
- (2015) Okhil K. Nag et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Advances and Challenges of Liposome Assisted Drug Delivery
- (2015) Lisa Sercombe et al. Frontiers in Pharmacology
- A “dose on demand” Biomarker Generator for automated production of [18F]F− and [18F]FDG
- (2014) V. Awasthi et al. APPLIED RADIATION AND ISOTOPES
- Preparation of DOPC and DPPC Supported Planar Lipid Bilayers for Atomic Force Microscopy and Atomic Force Spectroscopy
- (2013) Simon Attwood et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Post-modification of preformed liposomes with novel non-phospholipid poly(ethylene glycol)-conjugated hexadecylcarbamoylmethyl hexadecanoic acid for enhanced circulation persistence in vivo
- (2013) Okhil K. Nag et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Anti-Prostate-Specific Membrane Antigen Liposomes Loaded with 225Ac for Potential Targeted Antivascular -Particle Therapy of Cancer
- (2013) A. Bandekar et al. JOURNAL OF NUCLEAR MEDICINE
- Surface Engineering of Liposomes for Stealth Behavior
- (2013) Okhil Nag et al. Pharmaceutics
- Liposomal drug delivery systems: From concept to clinical applications
- (2012) Theresa M. Allen et al. ADVANCED DRUG DELIVERY REVIEWS
- Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods
- (2012) Koji Nakamura et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- A phase I study of liposomal-encapsulated docetaxel (LE-DT) in patients with advanced solid tumor malignancies
- (2012) John F. Deeken et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Prostate cancer epidemiology in the United States
- (2012) Otis W. Brawley WORLD JOURNAL OF UROLOGY
- 2-(3- -Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
- (2011) Y. Chen et al. CLINICAL CANCER RESEARCH
- Nanoparticle-based theranostic agents
- (2010) Jin Xie et al. ADVANCED DRUG DELIVERY REVIEWS
- Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA)
- (2010) Sachin S. Chandran et al. CANCER BIOLOGY & THERAPY
- One Step Radiosynthesis of 6-[18F]Fluoronicotinic Acid 2,3,5,6-Tetrafluorophenyl Ester ([18F]F-Py-TFP): A New Prosthetic Group for Efficient Labeling of Biomolecules with Fluorine-18
- (2010) Dag E. Olberg et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody
- (2009) T. A. ElBayoumi et al. CLINICAL CANCER RESEARCH
- Prostate cancer-specific monoclonal antibody 5D4 significantly enhances the cytotoxicity of doxorubicin-loaded liposomes against target cellsin vitro
- (2008) Rishikesh M. Sawant et al. JOURNAL OF DRUG TARGETING
- A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer
- (2008) K. P. Maresca et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nanoparticles for drug delivery in cancer treatment
- (2008) Barbara Haley et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started